The GLP-1 Revolution: Addressing India’s Unique Obesity Crisis
The Arrival of Generic GLP-1s in India As India grapples with its status as the world’s diabetes capital, pharmaceutical companies have begun introducing generic versions of GLP-1 receptor agonists, such as semaglutide, across the nation throughout 2024. These medications, originally designed for type 2 diabetes management, are now being deployed to combat a rapidly escalating…
